v3.26.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net loss $ (13,465,376) $ (95,698,885)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 109,726 1,914,851
Loss on issuance of senior secured convertible note 10,501,712 128,836,250
Change in fair value of convertible note and warrants 181,902 (37,145,000)
Amortization and depreciation 104,879 230,046
Amortization of right-of-use assets 137,374 148,514
Loss on disposition of non-controlling interest in subsidiary 217,657 0
Change in fair value of derivatives 0 (899,874)
Amortization of debt discount and financing fees 0 63,160
Loss on extinguishment of debt 0 151,925
Non-cash interest expense 0 (88,113)
Allowance for credit losses 128,360 145,743
Changes in Operating Assets and Liabilities:    
Accounts receivable (518,209) (398,333)
Note receivable 98,633 0
Other assets (141,180) (30,451)
Accounts payable 574,065 (609,457)
Accrued expenses 90,579 (89,255)
Contract liabilities 29,869 191,149
Security deposits and escrow payable 327,371 (71,895)
Operating lease liabilities (136,478) (143,404)
Net Cash Used in Operating Activities (1,759,116) (3,493,029)
Cash Flows from Investing Activities:    
Purchase of digital assets (8,142,127) 0
Cash sold with disposition (411,356) 0
Net Cash Provided by Investing Activities (8,553,483) 0
Cash Flows from Financing Activities:    
Borrowings on bank line of credit 0 4,493
Payments on bank line of credit 0 (8,851)
Proceeds from notes payable 9,900,000 3,408,585
Payments of deferred debt issuance costs 0 (138,895)
Payments on notes payable (54,661) (37,397)
Payments on advances of future receipts 0 (694,871)
Proceeds from issuance of preferred stock series C 100,000 0
Payments on post-acquisition consideration (30,000) (241,405)
Distributions to noncontrolling interest (170,895) 0
Repurchase of derivative instruments issued 0 (379,083)
Proceeds from issuance of common stock 3,446,087 2,919,192
Redemption of Series X Preferred Stock (1,700,000) 0
Net Cash Provided by Financing Activities 11,490,531 4,831,768
Net Increase in Cash, Cash equivalents and Restricted Cash 1,177,932 1,338,739
Cash, Cash equivalents and Restricted Cash at Beginning of Period 4,904,273 3,580,608
Cash, Cash equivalents and Restricted Cash at End of Period 6,082,205 4,919,347
Supplemental Disclosures of Cash Flow Information:    
Interest 7,041 327,118
Non-Cash Activities:    
Issuance of 3,500 shares of common stock for services rendered 44,450 1,906,815
Pro-rata expense recognition for restricted stock units 65,276  
Purchase of remaining portion of non-controlling interest 349,999  
Sell of controlling interest to minority interest 1,974,520  
Conversion of 4,380 shares of series B preferred stock into 105,128 shares of common stock 11 0
Office leases acquired under operating lease obligations 0 392,208
Reconciliation of Cash, Cash equivalents and Restricted Cash    
Cash and cash equivalents 1,742,636 2,853,535
Restricted Cash 4,339,569 2,065,812
Cash, Cash equivalents and Restricted Cash 6,082,205 4,919,347
Conversion of Liabilities Into Common Stock [Member]    
Non-Cash Activities:    
Issuance of 104,321 conversion of liabilities into common stock 6,482,912  
First Warrants and Principal and Interest Conversions [Member]    
Non-Cash Activities:    
Issuance of 104,321 conversion of liabilities into common stock $ 0  
Settlement of Notes Payable and Warrants [Member]    
Non-Cash Activities:    
Issuance of 104,321 conversion of liabilities into common stock   $ 812,379